This document provides an update on the safety of substances of human origin (SoHO) in relation to COVID-19. It reassesses the risk and proposes revised mitigation measures for preventing transmission through SoHO.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 13-19 August and includes updates on avian influenza A(H5N6), avian influenza A(H9N2), West Nile virus, COVID-19, poliomyelitis, and Crimean-Congo haemorrhagic fever.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 6 - 12 August 2023 and includes updates on measles, COVID-19, swine flu, mpox, diphtheria, West Nile virus, avian influenza, dengue, Crimean-Congo haemorrhagic fever, and invasive meningococcal disease.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 30 July - 5 August 2023 and includes updates on avian influenza, botulism, echovirus, West Nile virus, COVID-19, and Crimean-Congo haemorrhagic fever.
In 2019, 8 874 (7.4%) of patients staying in an intensive care unit (ICU) for more than two days presented with at least one ICU-acquired healthcare-associated infection (HAI) under surveillance (pneumonia, bloodstream infection, or urinary tract infection).
Between 2018 and 2020, nearly 20 000 surgical site infections (SSIs) were reported from a total of over 1.2 million surgical procedures in 13 EU/EEA countries participating in ECDC-coordinated SSI surveillance. Over 2 500 hospitals are part of this surveillance network.
In 2018, 9 860 (7.8%) of patients staying in an intensive care unit (ICU) for more than two days presented with at least one ICU-acquired healthcare-associated infection (HAI) under surveillance (pneumonia, bloodstream infection or urinary tract infection).
The 2016–2017 ECDC point prevalence survey was the second EU-wide point prevalence survey of healthcare-associated infections and antimicrobial use in acute care hospitals.